Citadel Advisors »

Global X Fds genomic biotech shares owned by Citadel Advisors

Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Global X Fds genomic biotech

Tip: Access up to 7 years of quarterly data

All positions including Global X Fds genomic biotech held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global X Fds genomic biotech by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $103k 12k 8.43
2025-03-31 $139k 18k 7.95
2024-12-31 $148k 15k 9.71
2024-03-31 $189k 17k 11.38
2022-12-31 $192k 15k 12.65
2021-12-31 $386k 19k 19.86
2021-09-30 $580k 26k 22.25
2021-06-30 $390k 16k 24.88
2020-12-31 $509k 22k 23.71
2020-06-30 $559k 32k 17.56

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Global X Fds genomic biotech

Sanctuary Advisors
IFP Advisors
Advisor Group Holdings
Global Retirement Partners

View all funds holding Global X Fds genomic biotech